According to Zhitong Finance APP, Hainan Huluwa Pharmaceutical Group (605199.SH) issued a risk warning announcement stating that the company's stock price has seen a significant short-term increase, which may indicate irrational speculation. However, the company's fundamentals have not undergone significant changes. The company specifically reminds investors to pay attention to secondary market trading risks, make rational decisions, and invest cautiously.

As of the announcement date, the company’s production and operation activities are normal, the market environment and industry policies have not undergone significant adjustments, production costs and sales have not experienced major fluctuations, internal production and operation order is normal, and there have been no significant changes in the main business. The company does not have any undisclosed information that should be disclosed.